Videos
Colorectal Cancer
Srdan Verstovsek, MD, PhD, discusses how to control symptoms while using hypomethylating agents in patients with myelofibrosis.
Thomas Powles, MD, shares his advice for community oncologists treating patients with bladder cancer in the frontline setting. According to Powles, this is a setting where there is a lot of uncertainty that can make decision making difficult.
Treatment Recommendations Upon Metastasis in CRPC
Optimal Management of Stage IIIA Hodgkin's Lymphoma
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Beyond SC Daratumumab: Emerging Therapeutic Approaches for Smoldering Myeloma
2
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
3
Melanoma Survival Is Tied to Comorbidity Burden, Illuminating Care Opportunities
4
MVR-T3011 Yields Efficacy and Safety in BCG-Unresponsive NMIBC
5
